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 ABSTRACT 
 Hyperketonemia interferes with the metabolic regula-
tion in dairy cows. It is assumed that metabolic and 
endocrine changes during hyperketonemia also affect 
metabolic adaptations during inflammatory processes. 
We therefore studied systemic and local intramammary 
effects of elevated plasma β-hydroxybutyrate (BHBA) 
before and during the response to an intramammary li-
popolysaccharide (LPS) challenge. Thirteen dairy cows 
received intravenously either a Na-dl-β-OH-butyrate 
infusion (n = 5) to achieve a constant plasma BHBA 
concentration (1.7 ± 0.1 mmol/L), with adjustments of 
the infusion rates made based on immediate measure-
ments of plasma BHBA every 15 min, or an infusion 
with a 0.9% NaCl solution (control; n = 8) for 56 h. 
Infusions started at 0900 h on d 1 and continued until 
1700 h 2 d later. Two udder quarters were challenged 
with 200 μg of Escherichia coli LPS and 2 udder quar-
ters were treated with 0.9% saline solution as control 
quarters at 48 h after the start of infusion. Blood 
samples were taken at 1 wk and 2 h before the start of 
infusions as reference samples and hourly during the 
infusion. Mammary gland biopsies were taken 1 wk 
before, and 48 and 56 h (8 h after LPS challenge) after 
the start of infusions. The mRNA abundance of key 
factors related to BHBA and fatty acid metabolism, 
and glucose transporters was determined in mammary 
tissue biopsies. Blood samples were analyzed for plasma 
glucose, BHBA, nonesterified fatty acid, urea, insulin, 
glucagon, and cortisol concentrations. Differences were 
not different for effects of BHBA infusion on the mRNA 
abundance of any of the measured target genes in the 
mammary gland before LPS challenge. Intramammary 
LPS challenge increased plasma glucose, cortisol, glu-
cagon, and insulin concentrations in both groups but 
increases in plasma glucose and glucagon concentration 
were less pronounced in the Na-dl-β-OH-butyrate infu-
sion group than in controls. In response to LPS chal-
lenge, plasma BHBA concentration decreased in con-
trols and decreased also slightly in the BHBA-infused 
animals because the BHBA concentration could not be 
fully maintained despite a rapid increase in BHBA infu-
sion rate. The change in mRNA abundance of citrate 
synthase in LPS quarters was significant between the 
2 treatment groups. The results indicate that elevated 
circulating BHBA concentration inhibits gluconeogen-
esis before and during immune response to LPS chal-
lenge, likely because BHBA can replace glucose as an 
energy source. 
 Key words:   metabolism ,  β-hydroxybutyrate ,  lipo-
polysaccharide challenge ,  mRNA abundance  
 INTRODUCTION 
 The markedly increased energy and nutrient require-
ments at simultaneously inadequate feed intake result 
in a negative energy balance (NEB) at the onset of 
lactation in dairy cows (van Dorland et al., 2009; Gross 
et al., 2011). A severe NEB leads to an increased mo-
bilization of fat stores, an elevated uptake of NEFA 
by the liver, and an increase in plasma ketone body 
concentration (Bobe et al., 2004; Gross et al., 2011). 
The concentration of plasma BHBA, which is the major 
circulating ketone body in ruminants, is increased as a 
compensatory response to handle the excessive NEFA 
release during the NEB. β-Hydroxybutyrate functions 
as an energy source in many tissues, especially during 
NEB, and it seems also to be used for citrate synthesis 
in the mammary gland (Bionaz and Loor, 2008). An 
increase in plasma BHBA concentration beyond the 
threshold of 1,200 μmol/L (Ospina et al., 2010) is gen-
erally accepted to represent the diagnosis of subclinical 
ketosis (Duffield et al., 2009). The increase in plasma 
ketone body concentration increases the risk of clinical 
ketosis, displaced abomasum, metritis, and subsequent 
decrease of milk production (Duffield et al., 2009). 
Elevated plasma BHBA concentration had a positive 
correlation with the severity of Escherichia coli masti-
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tis in an in vitro study (Kremer et al., 1993), and the 
risk of mastitis was much higher in subclinically ketotic 
dairy cows (Oltenacu and Ekesbo, 1994). An increase 
in plasma BHBA concentration to more than physi-
ological range impairs metabolism in animals (Müller et 
al., 1984; Schlumbohm and Harmeyer, 2004; Zarrin et 
al., 2013). From the present study, 2 papers have been 
already published. Induced hyperketonemia was shown 
decrease 2 plasma glucose and glucagon concentrations, 
whereas it did not affect milk yield, feed intake, insulin, 
NEFA, urea, cortisol, and enzymes involved in gluconeo-
genesis (Zarrin et al., 2013). In addition, BHBA infusion 
caused increased acute-phase protein mRNA abundance 
in the mammary gland but not in the liver. The LPS-
related increase in SCC was less pronounced, whereas 
mRNA abundance of IL-8 and IL-10 increased more in 
the response to LPS in the group receiving BHBA infu-
sion than in the control animals (Zarrin et al., 2014).
The use of intramammary LPS challenge to simulate 
IMI and to induce mastitis in dairy cows was established 
previously (Bruckmaier et al., 1993) to investigate the 
effect of mastitis on metabolism, immune responses, 
and performance in dairy cows. Evidence exists that 
LPS challenge affects metabolism and mRNA abun-
dance of inflammatory and other factors (Bruckmaier 
et al., 1993; Waldron et al., 2006; Vernay et al., 2012). 
In addition, it causes a decline of milk production (Ban-
nerman et al., 2003). However, no information exists 
about the effects of induced hyperketonemia at simul-
taneously even or positive energy balance on metabolic 
changes during mastitis.
The objective of this study was to induce long-term 
hyperketonemia beyond the threshold (1.2 mmol/L) 
through BHBA infusion for 56 h, and additionally 
stimulate the immune system by intramammary LPS 
challenge to investigate systemic metabolic effects and 
changes of the mRNA abundance of genes related to 
metabolism in mammary tissue before and during 
the LPS challenge in mid-lactation dairy cows. Genes 
involved in FA synthesis [FA synthase (FASN) and 
acetyl-CoA carboxylase], tricarboxylic acid cycle [ci-
trate synthase (CS)], mammary BHBA metabolism 
[BHBA dehydrogenase (BDH) 1, BDH2, succinyl-
CoA:3-ketoacid-coenzyme A transferase 1 (OXCT1)], 
and glucose transporters [glucose transporter (GLUT) 
1 and GLUT4] were selected to investigate the effects 
of elevated BHBA at simultaneously reduced glucose 
concentration on the mammary metabolism.
MATERIALS AND METHODS
Animals and Management
The animal trials followed the Swiss Law on Animal 
Protection and were permitted by the Committee of 
Animal Experiments of the Canton Fribourg, Switzer-
land. To study the specific effect of BHBA infusion 
without the usual endocrine and metabolic changes 
during the transition period, 13 multiparous Holstein 
dairy cows (parity 3.5 ± 0.1; mean ± SEM) in a later 
lactational stage [28.0 ± 0.3 (mean ± SEM) wk of lacta-
tion] were selected. Before the start of experiments, the 
health status of cows was checked by a routine blood 
glutaraldehyde coagulation test (Sandholm, 1976) and 
by measuring milk SCC (DeLaval cell counter DCC; 
Delaval International AB, Tumba, Sweden), which had 
to be less than 150 × 103 cells/mL in all 4 quarters. 
Milking was performed twice daily at 0530 and 1600 h.
Two weeks before the start of the experiment, ani-
mals were kept in a tie-stall barn for adaptation to the 
environment and feeding situations. All animals were 
fed ad libitum with hay (DM content = 890 g/kg of 
fresh matter on a DM basis, consisting of 153 g of CP/
kg, 235 g of crude fiber/kg, and 5.7 MJ of NEL/kg). In 
addition, they received a protein- and energy-rich con-
centrate [23.5% barley, 14.0% oats, 20.0% wheat bran, 
17.0% soybean expeller, 15.0% linseed meal, 0.6% salt, 
2.2% carbonate of lime, 0.4% calf rearing feed premix, 
4.0% molasses, and 3.0% bypass fat, on a DM basis 
(881 g/kg of fresh matter), consisting of 217 g of CP/
kg, 73.9 g of crude fiber/kg, and 7.6 MJ of NEL/kg, on 
a DM basis] twice daily according to individual milk 
production. Cows had free access to fresh water and 
minerals (50 g/cow) were supplied daily.
Experimental Design and Treatments
Thirteen dairy cows were randomly assigned to 
2 treatment groups. One group was intravenously 
infused with pyrogen-free and pH-balanced Na-dl-β-
OH-butyrate (HyperB; n = 5) to achieve an elevated 
plasma BHBA concentration (1.5 to 2.0 mmol/L), 
whereas the other group received a 0.9% saline solution 
(control; n = 8) for 56 h. The infusions started at 0900 
h on d 1 and continued until 1700 h 2 d later. Details 
on the preparation of solutions and infusion procedures 
are explained elsewhere (Zarrin et al., 2013).
At 48 h after infusion, 2 udder quarters were injected 
through the teat canal with 10 mL each of physiological 
NaCl (0.9%), including 200 μg of LPS E. coli serotype 
026:B6 (no. L8274; Sigma-Aldrich, St. Louis, MO), and 
designated as LPS quarters, and 10 mL of 0.9% NaCl 
was injected in 2 udder quarters as a control. Details 
are described elsewhere (Vernay et al., 2012).
Data Collection and Sampling
Blood Samples. Blood samples were taken 1 wk and 
2 h before the start of infusions at 0730 h, after milking, 
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and before feeding, as reference samples and with sam-
pling continuing hourly during the entire infusion pe-
riod. On the day before the start of infusions, cows were 
fitted with indwelling intravenous catheters (Cavafix 
Certo Splittocan; B. Braun Melsungen AG, Melsungen, 
Germany) with a length of 32 cm and a diameter of 16 
G in both jugular veins. Blood samples were collected 
into tubes, containing tripotassium EDTA, from the 
contralateral jugular catheter, which was not used for 
the infusion. Samples were immediately put on wet ice, 
centrifuged at 3,000 × g for 20 min at 4°C and plasma 
was stored at −20°C until analysis. During BHBA infu-
sion, additional small blood samples (1 mL) were taken 
and analyzed immediately for adjustment of BHBA 
infusion rates every 5 min for the first 2 h and every 1 
h thereafter.
Udder Biopsies. Details of the udder biopsy pro-
cedure were described by Vernay et al. (2012). In brief, 
1 wk before the start of infusions, before the LPS chal-
lenge (48 h after the start of infusions), and at the end 
of infusion (56 h; 8 h after the LPS stimulation) udder 
tissue was taken from the 2 rear quarters (1 LPS and 
1 control quarter). Before the biopsies, cows were se-
dated by an intravenous injection of 16 μg/kg of BW of 
xylazine (Xylazin Streuli ad us. vet.; G. Streuli & Co. 
AG, Uznach, Switzerland). Udder tissue (30 to 60 mg) 
was obtained under local anesthesia with 10 mL of 2% 
lidocaine (Streuli Pharma AG, Uznach, Switzerland) 
using a biopsy needle (12 G × 10 cm; Bard Magnum 
Core Tissue Biopsy Needle; Bard GmbH, Türkenfeld, 
Germany). The samples were placed immediately into 
an RNA stabilization reagent (RNAlater, Ambion; Ap-
plied Biosystems Inc., Austin, TX), kept at 4°C for 24 
h, and stored thereafter at −80°C until RNA extraction.
Laboratory Procedures
Blood Variables. Plasma glucose, BHBA, NEFA, 
and urea concentrations were measured enzymatically 
with an automated analyzer (Cobas Mira 2; Hoffmann-
La Roche, Basel, Switzerland), using commercial kits 
as described by van Dorland et al. (2009) and Kreipe 
et al. (2011). Plasma insulin concentration was mea-
sured by RIA as described by Vicari et al. (2008), and 
total cortisol was measured by RIA as described by 
Blum et al. (1985). Plasma glucagon concentration was 
measured by using a commercial RIA kit (catalog no. 
GL-32K; Millipore AG, Zug, Switzerland). In addition, 
the molar ratio of insulin:glucagon was calculated ac-
cording the formula suggested by Muller et al. (1971).
Udder Tissue. Total RNA was extracted from 
udder tissues with peqGOLD TriFast (PEQLAB Bio-
technologie GmbH, Erlangen, Germany). The quantity 
and purity of RNA was measured using a NanoDrop 
ND-2000 spectrophotometer (NanoDrop Technologies 
Inc., Wilmington, DE). Complementary DNA was syn-
thesized by reverse transcription of 1 μg of total mRNA 
with the RNA-dependent DNA polymerase Moloney 
Murine Leukemia Virus Reverse Transcriptase RNase 
H Minus, Point Mutant (MMLV-RT; Promega Corp., 
Madison, WI) and random hexamer primers (Invitro-
gen, Leek, the Netherlands). The mRNA abundances of 
housekeeping genes (GAPDH and ubiquitin) and target 
genes related to udder metabolism were measured by 
real-time quantitative PCR (qPCR) in a Rotor-Gene 
6000 rotary analyzer (Corbett Research, Sydney, Aus-
tralia) using the software version 1.7.75. The cycle 
threshold (CT) values obtained from candidate genes 
were adjusted according the mean of the housekeep-
ing gene CT according to the following equation: ΔCT 
= CT (arithmetic mean of housekeeping genes) − CT 
(target gene). Differences in mRNA abundance of can-
didate genes (based on CT values) before the start of 
infusions and 48 h after the start of infusions were cal-
culated as follows: ΔΔCT = ΔCT [d 3 (0 h)] − ΔCT 
(d 0), and differences in mRNA abundance by LPS 
challenge were calculated for LPS and control quarters 
separately according to this equation: ΔΔCT = ΔCT 
[d 3 (8 h)] − ΔCT [d 3 (0 h)]. The primer sequences 
for FASN, CS, acetyl-CoA carboxylase, BDH2, GLUT1, 
and GLUT4 were published elsewhere (Graber et al., 
2010). Succinyl-CoA:3-ketoacid-coenzyme A trans-
ferase 1 and BDH1 primers were designed to amplify 
cDNA. Selected primer sequences of housekeeping and 
measured genes encoding for mammary gland metabo-
lism are shown in Table 1. The means ± standard error 
of the mean of mRNA levels of GAPDH and ubiquitin 
were stable across time points (baseline, 48 h after in-
fusions, and at the end of infusions) and treatments 
(HyperB and NaCl) are shown in Table 2.
Statistical Analysis
Before the statistical evaluation, all data were tested 
for normality in SAS (Release 9.2; SAS Institute Inc., 
Cary, NC; PROC UNIVARIATE plot normal), and all 
parameters followed a normal distribution. The changes 
(differences between before and 48 h after the start 
of infusions, and before and after LPS administration) 
were calculated for mRNA abundance of target genes. 
The area under the curve (AUC) was calculated for 
blood variables during the LPS challenge (8.5 h) by 
the trapezoidal rule (combination of rectangular and 
triangular area compartments). The respective plasma 
concentration before the start of infusion was used as 
baseline value.
The changes in mRNA abundance of measured 
genes and the AUC of blood variables were analyzed 
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by using the general linear models (GLM) procedure 
of SAS, including treatment (BHBA or NaCl) as fixed 
effect. Differences between means were localized by 
the Tukey test. In addition, means of delta values 
obtained within each treatment were tested for their 
difference from 0. Differences in blood plasma vari-
ables between treatments within each time point and 
between time points within treatments were evaluated 
by using the PROC MIXED of SAS, including treat-
ment (BHBA or NaCl), time, and their interaction 
as fixed effects, and cows as repeated subject. The 
Tukey-Kramer test was used for adjustment of mul-
tiple comparisons. The compound symmetry structure 
was used for variance-covariance matrix for repeated 
measures within animals. Data are presented as means 
± standard error of the mean and differences were 
considered significant at P < 0.05.
RESULTS
Feed Intake, Milk Yield, and Infusion Rates  
and Concentrations of Plasma Variables
As previously reported (Zarrin et al., 2013), DMI and 
milk yield were not affected by 48-h BHBA infusion. 
Intramammary LPS challenge decreased DMI and milk 
yield in both treatment groups, whereas these variables 
were not affected by treatment (Table 3).
The AUC of plasma variable concentrations in the 
HyperB and control groups during the LPS challenge 
(8.5 h) is shown in Table 4. The mean BHBA infu-
sion rate and plasma BHBA concentration in HyperB 
and control groups during −24 to −48 h of infusion 
and hourly after LPS challenge are shown in Figure 1. 
The mean infusion rate of BHBA over 48 h was 8.1 ± 
Table 1. Polymerase chain reaction primer information (For = forward; Rev = reverse), annealing temperature, and the PCR product length 
Gene1 Primer sequence 5c–3c
GenBank  
accession no.
Annealing  
temperature 
(°C)
Length  
(bp)
FA synthesis-related variable
 ACoAC For: CTCTTCCGACAGGTTCAAGC AJ-132890 61 248
Rev: ACCATCCTGGCAAGTTTCAC
 FASN For: CTGAGTCGGAGAACCTGGAG NM_001012669 63 232
Rev: ACAATGGCCTCGTAGGTGAC
BHBA metabolism-related variable
 BDH1 For: GAGTGAGAGCGGGTAAGGGT NM_001034600.2 61 199
Rev: GGCCACAAAAGGCAGAATGG
 BDH2 For: TGCAACTGTGTGTGTCCAG NM_001034488.2 58 175
Rev: CAGATTCATCAGAGGCCAAG
 OXCT1 For: ATGGTGACCTGGCTAACTGG NM_001076070.2 60 234
Rev: TCAGACCCTTTTTGCTGTCC
Citrate synthase
 CS For: TGGACATGATGTATGGTGG BC-114138 60 217
Rev: AGCCAAGATACCTGTTCCTC
Glucose transporter
 GLUT1 For: GCTTCTCCAACTGGACTTCG NM_174602 60 225
Rev: ACAGCTCCTCAGGTGTCTTG
 GLUT4 For: GACTGGTACCCATGTACGTG NM_174604.1 60 242
Rev: CCGGATGATGTAGAGGTAGC
Housekeeping gene
 GAPDH For: GTC TTC ACT ACC ATG GAG AAG G NM001034034 60 197
Rev: TCA TGG ATG ACC TTG GCC AG
 Ubiquitin For: AGA TCC AGG ATA AGG AAG GCA T NM174133 62 198
Rev: GCT CCA CCT CCA GGG TGA T
1ACoAC = acetyl-CoA carboxylase; FASN = FA synthase; BDH1 = BHBA dehydrogenase 1; BDH2 = BHBA dehydrogenase 2; OXCT1 = 
succinyl-CoA:3-ketoacid-coenzyme A transferase 1; CS = citrate synthase; GLUT1 = glucose transporter 1; GLUT4 = glucose transporter 4.
Table 2. Means ± SEM of mRNA levels [cycle threshold (CT)] of housekeeping genes across time points and 
treatments 
Gene Treatment1 Baseline
48 h after  
infusions
End of  
infusions
GAPDH HyperB 18.6 ± 0.3 17.9 ± 0.2 17.3 ± 0.1
NaCl 19.9 ± 0.7 19.3 ± 0.7 17.8 ± 0.7
Ubiquitin HyperB 16.8 ± 0.4 17.2 ± 0.7 16.6 ± 0.2
NaCl 19.1 ± 0.4 18.5 ± 0.3 18.1 ± 0.5
1HyperB = infusion with BHBA (n = 5); NaCl = infusion with physiological saline solution (n = 8).
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0.3 μmol/kg per minute. During 48-h BHBA infusion, 
the mean plasma BHBA concentration was maintained 
at 1.7 ± 0.1 mmol/L in the HyperB group, and the 
plasma BHBA concentration in the control group was 
0.6 ± 0.1 mmol/L. Intramammary LPS challenge de-
creased plasma BHBA concentration in the HyperB 
group from 1.7 ± 0.1 to 1.4 ± 0.1 mmol/L (P < 0.001) 
despite increased infusion rate. In the control group, 
plasma BHBA concentration decreased from 0.6 ± 0.1 
to 0.4 ± 0.1 mmol/L (P < 0.01) compared with be-
fore LPS challenge. Because of the adjustment of the 
BHBA infusion rate to maintain hyperketonemia in the 
HyperB group, the mean BHBA infusion rate needed 
to be significantly increased (P < 0.001) to 11.1 μmol/
kg per minute after LPS administration. Despite the 
increased BHBA infusion rate in the HyperB group, the 
plasma BHBA concentration decreased in both groups 
(P < 0.05; i.e., due to the fast change in BHBA plasma 
concentration, the maintenance of hyperketonemia in 
the HyperB group through increased infusion rate was 
not completely successful).
Plasma glucose, glucagon, insulin, NEFA, urea, 
and cortisol concentrations and the molar ratio of 
insulin:glucagon before the LPS challenge (average 
of 24–48 h of infusion), hourly after LPS stimulation 
(8.5 h), and their differences within treatments and 
between each time points are shown in Figures 2A, 2B, 
2C, 3A, 3B, 3C, and 4. Compared with the plasma 
glucose concentration before the LPS challenge, intra-
mammary LPS administration caused an increase in 
plasma glucose concentration in both infusion groups 
up to 90 min. Plasma glucose concentration was de-
creased at 150 min after the LPS challenge, after that 
increased again at 210 min, and finally decreased to 
the same concentration as before LPS administration. 
The increase in plasma glucose concentration after LPS 
administration was lower in HyperB than in the control 
(P < 0.05; Figure 2A; Table 4).
On the second day of hyperketonemia, treated cows 
had, on average, lower glucagon concentrations than 
control cows. Intramammary LPS treatment increased 
the glucagon concentration after 3.5 h, which persisted 
for the remaining sampling period (8.5 h). During this 
time period, glucagon concentrations were lower in 
hyperketotic than control cows (P < 0.05; Figure 2B), 
indicating that hyperketonemia attenuates the LPS-
induced glucagon secretion (P < 0.05; Table 4).
In comparison with 48-h BHBA infusion, plasma 
insulin increased (P < 0.05; Figure 2C) in response to 
LPS challenge and reached a peak at 210 min in the 
HyperB group and at 270 min in the control group. 
Based on the AUC, plasma insulin concentration did 
not differ between the HyperB and control groups (Ta-
ble 4). Plasma NEFA concentration was not affected 
by the LPS challenge and BHBA infusion (Figure 3A; 
Table 4).
Table 3. Milk yield and DMI (mean ± SEM) of dairy cows infused with BHBA (HyperB; n = 5) or saline (NaCl; n = 8) before the start of the 
infusion (d 0), second day of infusion (d 2), and third day of infusion (day of LPS challenge) 
Variable Treatment
Time relative to infusion P-value
d 0 d 2
d 3  
(LPS challenge) Treatment Time
Treatment  
× time
Milk yield (kg/d) HyperB 24.9 ± 2.6 22.0 ± 2.6 13.0 ± 2.6 0.94 <0.01 0.43
NaCl 23.0 ± 2.3 20.6 ± 2.0 16.7 ± 2.0
DMI (kg/d) HyperB 19.9 ± 1.9 19.0 ± 1.9 8.5 ± 1.9 0.41 <0.001 0.17
NaCl 19.4 ± 1.7 18.1 ± 1.5 13.5 ± 1.5
Table 4. Plasma variable concentrations in dairy cows infused with BHBA (HyperB; n = 5) or saline (NaCl; n = 8) during the LPS challenge1 
Variable
Treatment P-value
NaCl HyperB
NaCl vs.  
baseline
HyperB vs.  
baseline
HyperB  
vs. NaCl
Glucose (mmol/L·h) 4.3 ± 0.1 3.8 ± 0.1 0.01 0.30 0.02
BHBA (mmol/L·h) 0.4 ± 0.0 1.4 ± 0.1 0.03 <0.001 <0.001
NEFA (mmol/L·h) 0.1 ± 0.0 0.1 ± 0.0 0.81 0.20 0.76
Urea (mmol/L·h) 4.0 ± 0.3 3.7 ± 0.3 0.02 0.07 0.44
Cortisol (ng/mL·h) 13.8 ± 1.5 14.7 ± 2.0 <0.001 0.001 0.73
Insulin (mU/L·h) 35.0 ± 5.4 34.8 ± 6.9 <0.001 0.01 0.97
Glucagon (pg/mL·h) 221.7 ± 15.3 161.2 ± 19.3 <0.001 0.08 0.03
Insulin:glucagon (molar ratio·h) 3.7 ± 0.7 4.4 ± 0.9 0.03 0.02 0.52
1Data are presented as LSM ± SEM of area under the curve (AUC) during 8 h. The AUC was calculated according to the trapezoidal rule.
3536 ZARRIN ET AL.
Journal of Dairy Science Vol. 97 No. 6, 2014
Intramammary LPS administration induced a de-
crease in plasma urea concentration only in the first 
90 min after the LPS challenge in the HyperB group, 
whereas LPS challenge decreased the plasma urea con-
centration in the first 30 min in the control group (P < 
0.05; Figure 3B). Urea concentrations were not affected 
by infusion treatments (Table 4).
Plasma cortisol concentration was increased at 90 
min after the intramammary LPS stimulation in both 
treatment groups (P < 0.05; Figure 3C), but based on 
the AUC, cortisol concentration did not differ between 
the HyperB and control groups (Table 4).
The insulin:glucagon molar ratio was not affected by 
the treatments at the second day of infusion and during 
the LPS challenge, whereas it was affected by intrama-
mmary LPS challenge at 3.5 and 4.5 h in the HyperB 
and control groups, respectively (Figure 4; Table 4).
mRNA Abundance of Candidate Genes  
Related to Mammary Gland Metabolism
mRNA Abundance Related to Mammary Me-
tabolism During the 48 h of BHBA Infusion. 
The mRNA abundance of genes related to mammary 
gland metabolism before and 48 h after the start of 
infusions are shown in Table 5. Fatty acid synthase 
mRNA abundance decreased within the HyperB group 
during 48 h of BHBA infusion (P < 0.05; Table 5). The 
mRNA abundances of the other candidate genes were 
not affected by 48-h BHBA infusion.
mRNA Abundance of Genes Related to Mam-
mary Metabolism During the LPS Challenge. For 
both groups, differences between mRNA abundance of 
genes related to mammary gland metabolism before 
and after the LPS challenge in quarters stimulated with 
intramammary LPS and control quarters are shown in 
Table 6. Citrate synthase mRNA abundance in LPS 
quarters increased in the HyperB group and decreased 
in the control group after the LPS challenge (P < 0.05; 
Table 6). Intramammary LPS challenge decreased 
mRNA abundance of BDH2, FASN, and OXCT1 in 
LPS quarters of both treatment groups, and decreased 
BDH1 and GLUT4 mRNA abundance in the control 
group (P < 0.05). Infusion of BHBA decreased BDH2 
mRNA abundance in control quarters in the HyperB 
group (P < 0.05) after the LPS challenge. The mRNA 
abundance of other candidate genes in control quarters 
were not affected by LPS challenge and BHBA infusion 
in both treatment groups.
DISCUSSION
To our best knowledge, this experiment is the first 
study to investigate effects of an induced long-term (56 
h) hyperketonemia, without other metabolic effects of 
NEB, on mammary gland metabolism and metabolic 
and endocrine parameters in combination with an acti-
vation of immune response by an intramammary LPS 
administration in mid-lactation dairy cows.
The effects of induced hyperketonemia for 48 h on 
blood metabolites, feed intake, mRNA abundance of 
candidate genes related to hepatic metabolism, and milk 
yield have been reported earlier (Zarrin et al., 2013). 
The moderate effects of BHBA infusion on mammary 
gland metabolism at the mRNA level confirmed that 
milk synthesis was not affected by intravenous BHBA 
infusion in mid-lactation dairy cows (Zarrin et al., 
2013). The lacking effect on milk synthesis was likely 
due to the related low needs of glucose for mammary 
lactose synthesis and other metabolic processes at this 
lactational stage compared with early lactation. Thus, 
the reduced plasma glucose levels during BHBA infu-
sion were likely not limiting for milk secretion.
Intramammary LPS challenge decreased plasma 
BHBA concentration in both treatment groups. The 
goal to maintain plasma BHBA at 1.7 mmol/L through 
an increased BHBA infusion rate could not be achieved 
because the decline in plasma BHBA concentration was 
faster than the possible adjustment of infusion rate. 
Waldron et al. (2003) suggested that the decline in plas-
ma BHBA concentration was related to the suppression 
of ruminal epithelium ketogenesis capacity after LPS 
Figure 1. Mean BHBA infusion rate during −24 to −48 h of infu-
sion (24–48h inf) and hourly after LPS challenge (510 min) in BHBA 
cows (HyperB; n = 5). Mean plasma BHBA concentration in cows 
infused with BHBA (HyperB) and control cows (NaCl; n = 8) during 
48 h of infusion, −24 to −48 h average and hourly after LPS challenge 
(510 min). Values represent mean ± SEM. The open squares with 
plus signs show significant differences (P < 0.05) of BHBA infusion 
rate during the LPS challenge to mean infusion rates in −24 to −48 
h. The closed circles and open circles show significant differences (P 
< 0.05) between −24 to −48 h average and each time point during 
the LPS challenge for the HyperB and NaCl groups, respectively. The 
closed rectangles indicate significant differences between the 2 treat-
ment groups during the LPS challenge (P < 0.05).
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challenge. Because the decline in BHBA concentration 
after LPS administration was quite rapid and pro-
nounced, a contribution of changed ruminal absorption 
may be excluded. Despite not doing a mammary LPS 
challenge, intramuscularly applied LPS in a different 
species decreased hepatic ketogenesis capacity (Memon 
et al., 1992), whereas LPS administration did not affect 
hepatic ketogenesis capacity in incubated liver slices of 
dairy cows (Waldron et al., 2003). Based on the fast 
and huge changes in plasma BHBA concentration in 
BHBA-infused animals in the present study, this ef-
fect seems very unlikely. Recent findings showed that 
LPS challenge increased milk BHBA concentration in 
LPS-treated quarters during an induced hyperketone-
mia (Lehmann et al., 2013). Thus, a certain quantity of 
BHBA is lost with the secreted milk in LPS-stimulated 
quarters. However, this portion does not seem to be 
quantitatively of great importance because milk secre-
tion is reduced in the quarters treated with LPS.
A transient increase and a subsequent decrease in 
plasma glucose concentration after LPS challenge in 
both groups in this study was consistent with previous 
studies that illustrated transient hyperglycemia after 
E. coli endotoxin-induced mastitis (Bruckmaier et al., 
1993), with increased and subsequent decreased plasma 
glucose concentration after LPS challenge (Werling et 
al., 1996). Hypoglycemia after the LPS challenge can 
also be attributed to increases in cytokines such as tu-
mor necrosis factor α and IL-1β (Schmitz et al., 2004; 
Vernay et al., 2012; Zarrin et al., 2014), which increase 
glucose utilization during the LPS challenge (Stouthard 
et al., 1995). Regarding the increase in plasma glucose 
concentration after the LPS challenge, during a simi-
lar immune stimulation via LPS challenge previously, 
development of insulin resistance was reported and, in 
this case, the glucose infusion rate had to be reduced 
to avoid an increase in plasma glucose concentration; 
thus, additional glucose was available through either 
glycogenolysis or gluconeogenesis (Vernay et al., 2012). 
Based on present data it seems that the initial increase 
in plasma glucose concentration after LPS challenge is 
not related to glycogenolysis, because LPS challenge 
increased plasma glucagon concentration 150 min after 
LPS administration. The difference between plasma 
glucose concentrations in the 2 experimental groups af-
ter the LPS challenge was related to the BHBA infusion 
that decreased glucose production besides decreasing 
gluconeogenesis during LPS. The low plasma glucose 
concentration in the HyperB group rather than in the 
control group may be related to the reduced increase 
in plasma glucagon concentration in HyperB compared 
with the control group, which resulted in low glucose 
production from gluconeogenesis or glycogen storage 
(Zarrin et al., 2013).
Figure 2. Mean plasma glucose (A), glucagon (B), and insulin (C) 
concentrations in cows infused with BHBA (HyperB; n = 5) and con-
trol cows (NaCl; n = 8) during 48 h of infusion (−24 to −48 h average) 
and hourly after LPS challenge (510 min). Values represent mean ± 
SEM. The closed circles and open circles show significant differences 
(P < 0.05) between −24 to −48 h average and each time point during 
the LPS challenge for the HyperB and NaCl groups, respectively. The 
closed rectangles indicate significant differences between the 2 treat-
ment groups during the LPS challenge (P < 0.05).
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Intramammary LPS challenge did not affect plasma 
NEFA concentration in the present study. This finding 
is in agreement with a previous study that showed that 
intramammary LPS challenge did not affect plasma 
NEFA concentration, whereas plasma NEFA concentra-
tion increased in control cows that received NaCl (Wal-
dron et al., 2006). The results of the present study are 
in contrast with a previous study where different doses 
of LPS were administrated intravenously for 100 min 
in mid-lactation dairy cows and plasma NEFA tended 
to increase after LPS challenge (Waldron et al., 2003). 
In our previous study, intramammary LPS challenge 
caused a decrease in plasma NEFA concentration in 
mid-lactation dairy cows during hypoglycemic and eu-
glycemic clamping, which manipulated plasma glucose 
concentration (Vernay et al., 2012). It can be assumed 
that in the present study, the unaffected plasma NEFA 
concentration following LPS challenge was related to 
the use of BHBA as an alternative energy source, which 
could diminish the mobilization of FA from fat stores in 
the HyperB group.
As previously observed in response to intramammary 
LPS administration (Lehtolainen et al., 2003; Waldron 
et al., 2006; Vernay et al., 2012), plasma cortisol con-
centration increased in both treatment groups. Proin-
flammatory cytokines and possibly also the handling 
of the animals during the experiments likely activated 
the hypothalamus-pituitary-gland axis and increased 
the synthesis of glucocorticoids (Beishuizen and Thijs, 
Figure 3. Mean plasma NEFA (A), urea (B), and cortisol (C) con-
centrations in cows infused with BHBA (HyperB; n = 5) and control 
cows (NaCl; n = 8) during 48 h of infusion (−24 to −48 h average) 
and hourly after LPS challenge (510 min). Values represent mean ± 
SEM. The closed circles and open circles show significant differences 
(P < 0.05) between −24 to −48 h average and each time point during 
the LPS challenge for the HyperB and NaCl groups, respectively. The 
closed rectangle indicates significant difference between the 2 treat-
ment groups during the LPS challenge (P < 0.05).
Figure 4. Insulin:glucagon molar ratio in cows infused with BHBA 
(HyperB; n = 5) and control cows (NaCl; n = 8) during 48 h of infu-
sion (−24 to −48 h average) and hourly after LPS challenge (510 min). 
Values represent mean ± SEM. The closed circles and open circles 
show significant differences (P < 0.05) between −24 to −48 h average 
and each time point during the LPS challenge for the HyperB and 
NaCl groups, respectively. The closed rectangle indicates significant 
difference between the 2 treatment groups during the LPS challenge 
(P < 0.05).
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2003). Elevation of plasma cortisol concentration may 
be partially responsible for the observed induction of 
insulin resistance (Andrews and Walker, 1999) to pro-
vide more glucose for the immune reaction.
The increase in glucagon concentration after LPS 
administration is in agreement with Waldron et al. 
(2003), who reported plasma glucagon concentration 
being increased at 2 h after the LPS challenge and 
Table 5. Changes in mRNA abundance of genes related to mammary gland metabolism during 48 h of infusion 
with BHBA (HyperB; n = 5) or saline (NaCl; n = 8) 
Gene1 Group Delta2
ANOVA  
(P-value, group)
FA synthesis-related variable
 ACoAC HyperB −1.0 ± 0.5 0.16NaCl 0.0 ± 0.4
 FASN HyperB −1.0 ± 0.3* 0.13NaCl −0.2 ± 0.5
BHBA metabolism-related variable
 BDH1 HyperB −0.9 ± 0.5 0.49NaCl −0.2 ± 0.6
 BDH2 HyperB 0.1 ± 0.4 0.53NaCl 0.6 ± 0.6
 OXCT1 HyperB −0.5 ± 0.3 0.66NaCl −0.2 ± 0.4
Citrate synthase
 CS HyperB −0.2 ± 0.3 0.86NaCl −0.1 ± 0.4
Glucose transporter
 GLUT1 HyperB −0.4 ± 0.2 0.88NaCl −0.5 ± 0.7
 GLUT4 HyperB 0.6 ± 0.5 0.14NaCl −0.4 ± 0.4
1ACoAC = acetyl-CoA carboxylase; FASN = FA synthase; BDH1 = BHBA dehydrogenase 1; BDH2 = BHBA 
dehydrogenase 2; OXCT1 = succinyl-CoA:3-ketoacid-coenzyme A transferase 1; CS = citrate synthase; GLUT1 
= glucose transporter 1; GLUT4 = glucose transporter 4.
2Differences between before and 48 h after the start of infusions. Values represent mean ± SEM.
*Delta is different from 0 (P < 0.05).
Table 6. Differences in mRNA abundance related to metabolism in the mammary gland during the LPS challenge in LPS and control quarters 
in dairy cows infused with BHBA (HyperB; n = 5) or saline (NaCl; n = 8) 
Gene1 Group
LPS delta  
(after LPS –  
before LPS)2
ANOVA  
(P-value,  
group)
Control delta  
(after LPS –  
before LPS)2
ANOVA  
(P-value,  
group)
FA synthesis-related variable
 ACoAC HyperB −0.9 ± 0.7 0.66 −0.6 ± 0.5 0.58NaCl −0.5 ± 0.6 −1.1 ± 0.7
 FASN HyperB −4.4 ± 0.7* 0.60 −1.0 ± 1.2 0.47NaCl −3.8 ± 0.8* −0.2 ± 0.5
BHBA metabolism-related variable
 BDH1 HyperB −1.4 ± 0.9 0.37 −1.6 ± 1.1 0.96NaCl −2.7 ± 0.9* −1.7 ± 0.8
 BDH2 HyperB −2.6 ± 0.4* 0.87 −1.3 ± 0.5* 0.62NaCl −2.4 ± 0.8* −1.0 ± 0.5
 OXCT1 HyperB −1.8 ± 0.3* 0.25 0.3 ± 0.7 0.56NaCl −1.0 ± 0.5* 1.7 ± 1.8
Citrate synthase
 CS HyperB 0.5 ± 0.3 0.05 −0.4 ± 0.3 0.35NaCl −0.5 ± 0.3 0.3 ± 0.5
Glucose transporter
 GLUT1 HyperB −0.4 ± 0.4 0.74 0.4 ± 0.4 0.85NaCl −0.5 ± 0.2 0.3 ± 0.5
 GLUT4 HyperB −0.9 ± 0.9 0.24 0.8 ± 0.8 0.24NaCl −2.0 ± 0.5* 0.4 ± 0.6
1ACoAC = acetyl-CoA carboxylase; FASN = FA synthase; BDH1 = BHBA dehydrogenase 1; BDH2 = BHBA dehydrogenase 2; OXCT1 = 
succinyl-CoA:3-ketoacid-coenzyme A transferase 1; CS = citrate synthase; GLUT1 = glucose transporter 1; GLUT4 = glucose transporter 4.
2Values are represented as mean ± SEM.
*Delta is different from 0 (P < 0.05).
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staying at a high level up to 8 h after the start of 
LPS challenge. In the current study, increased plasma 
glucagon concentration in both groups was observed at 
150 min after the intramammary LPS administration. 
However, the increase in plasma glucagon concentra-
tion during LPS challenge was much less in cows that 
received BHBA compared with controls. As reported 
previously, BHBA infusion decreased glucagon secre-
tion (Zarrin et al., 2013), probably mediated by the 
inhibitory effect of gamma amino butyric acid (GABA) 
on glucagon secretion (Adeghate et al., 2000; Wendt et 
al., 2004), which increased in the epileptic brain in the 
presence of high plasma BHBA concentration (Suzuki 
et al., 2009). The less pronounced increase in glucagon 
concentration during LPS challenge in the HyperB 
group was likely related to a lower need for glucose for 
the immune response than in the control group and, 
thus, less activation of gluconeogenesis. This effect is 
another indicator for BHBA to be an alternative energy 
source.
An increased plasma insulin concentration in re-
sponse to the LPS challenge in the present study is in 
agreement with previous studies (Waldron et al., 2003, 
2006; Vernay et al., 2012). Despite the inhibitory ef-
fect of insulin on glucagon secretion (Weir et al., 1976), 
plasma glucagon concentration increased after LPS 
challenge. The effect of LPS challenge on glucoregula-
tory hormones is most likely related to effects of proin-
flammatory cytokines (Eizirik et al., 1995; Andersson 
et al., 2001), which stimulate the pancreatic production 
and release of these hormones.
The effect of the intramammary LPS challenge 
on FASN, OXCT1, and BDH2 mRNA abundance in 
quarters stimulated with LPS in both groups, and de-
crease in CS mRNA abundance in the control group 
showed that LPS challenge negatively affects mammary 
gland metabolism and milk synthesis, which had been 
reported before (Waldron et al., 2003, 2006). The in-
crease in CS mRNA abundance in the HyperB group 
after LPS challenge is in agreement with Bionaz and 
Loor (2008), who suggested that the major product of 
BHBA metabolism in the bovine mammary gland is 
citrate, which is increased in milk. It can be assumed 
that the upregulation of mammary gland CS mRNA 
abundance in the HyperB group confirmed that BHBA 
can be partly used to produce energy through the tri-
carboxylic acid cycle by mammary gland (Palmquist et 
al., 1969).
CONCLUSIONS
Results demonstrate that BHBA represents an al-
ternative energy source for the mammary tissues and 
for the immune system. With respect to milk secretion 
and the related specific need of glucose, the BHBA-
induced adaptions may cause an inadequate decline in 
plasma glucose concentration. It can be speculated that 
the resulting low plasma glucose concentration also 
negatively affects the immune response. The current 
results may reflect the negative effect of spontaneous 
hyperketonemia on hepatic gluconeogenesis by provid-
ing less glucose. Long-term reduced glucose availability 
caused by hyperketonemia might lower the productive 
performance of dairy cows.
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